Literature DB >> 21216150

Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.

Varnavas D Mouchlis1, Victoria Magrioti, Efrosini Barbayianni, Nathan Cermak, Rob C Oslund, Thomas M Mavromoustakos, Michael H Gelb, George Kokotos.   

Abstract

Group IIA secreted phospholipase A₂ (GIIA sPLA₂) is a member of the n class="Species">mammalian sPLA₂ enzyme family and is associated with various inflammatory conditions. In this study, the synthesis of 2-oxoamides based on α-amino acids and the in vitro evaluation against three secreted sPLA₂s (GIIA, GV and GX) are described. The long chain 2-oxoamide GK126 based on the amino acid (S)-leucine displayed inhibition of human and mouse GIIA sPLA₂s (IC₅₀ 300nM and 180nM, respectively). It also inhibited human GV sPLA₂ with similar potency, while it did not inhibit human GX sPLA₂. The elucidation of the stereoelectronic characteristics that affect the in vitro activity of these compounds was achieved by using a combination of simulated annealing to sample low-energy conformations before the docking procedure, and molecular docking calculations. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21216150      PMCID: PMC3050527          DOI: 10.1016/j.bmc.2010.12.030

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  40 in total

Review 1.  A review of protein-small molecule docking methods.

Authors:  R D Taylor; P J Jewsbury; J W Essex
Journal:  J Comput Aided Mol Des       Date:  2002-03       Impact factor: 3.686

2.  Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.

Authors:  David A Six; Efrosini Barbayianni; Vassilios Loukas; Violetta Constantinou-Kokotou; Dimitra Hadjipavlou-Litina; Daren Stephens; Alan C Wong; Victoria Magrioti; Panagiota Moutevelis-Minakakis; Sharon F Baker; Edward A Dennis; George Kokotos
Journal:  J Med Chem       Date:  2007-08-02       Impact factor: 7.446

Review 3.  Inhibitors of secretory phospholipase A2 group IIA.

Authors:  Robert C Reid
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 4.  Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease.

Authors:  Robert S Rosenson
Journal:  Cardiovasc Drugs Ther       Date:  2009-01-14       Impact factor: 3.727

Review 5.  Structure and catalytic mechanism of secretory phospholipases A2.

Authors:  D L Scott; P B Sigler
Journal:  Adv Protein Chem       Date:  1994

6.  D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity.

Authors:  Karl A Hansford; Robert C Reid; Chris I Clark; Joel D A Tyndall; Michael W Whitehouse; Tom Guthrie; Ross P McGeary; Karl Schafer; Jennifer L Martin; David P Fairlie
Journal:  Chembiochem       Date:  2003-03-03       Impact factor: 3.164

7.  Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.

Authors:  D L Scott; S P White; J L Browning; J J Rosa; M H Gelb; P B Sigler
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

Review 8.  Phospholipase A2 biochemistry.

Authors:  John E Burke; Edward A Dennis
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-18       Impact factor: 3.727

9.  Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.

Authors:  Rob C Oslund; Nathan Cermak; Michael H Gelb
Journal:  J Med Chem       Date:  2008-07-08       Impact factor: 7.446

Review 10.  Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2.

Authors:  Christina C Leslie
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-04       Impact factor: 4.006

View more
  9 in total

Review 1.  Phospholipase A2 catalysis and lipid mediator lipidomics.

Authors:  Varnavas D Mouchlis; Edward A Dennis
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-23       Impact factor: 4.698

2.  Design of Selective sPLA2-X Inhibitor (-)-2-{2-[Carbamoyl-6-(trifluoromethoxy)-1H-indol-1-yl]pyridine-2-yl}propanoic Acid.

Authors:  Fabrizio Giordanetto; Laurent Knerr; Peter Nordberg; Daniel Pettersen; Nidhal Selmi; Hans-Georg Beisel; Hannah de la Motte; Åsa Månsson; Mikael Dahlström; Johan Broddefalk; Gabrielle Saarinen; Fredrik Klingegård; Eva Hurt-Camejo; Birgitta Rosengren; Johannes Wikström; Maria Wågberg; Johan Brengdahl; Mattias Rohman; Jenny Sandmark; Tomas Åkerud; Robert G Roth; Frank Jansen; Marie Ahlqvist
Journal:  ACS Med Chem Lett       Date:  2018-06-23       Impact factor: 4.345

3.  Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics.

Authors:  Varnavas D Mouchlis; Vasiliki Michopoulou; Violetta Constantinou-Kokotou; Thomas Mavromoustakos; Edward A Dennis; George Kokotos
Journal:  J Chem Inf Model       Date:  2012-01-10       Impact factor: 4.956

4.  Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.

Authors:  Sofia Vasilakaki; Efrosini Barbayianni; Georgios Leonis; Manthos G Papadopoulos; Thomas Mavromoustakos; Michael H Gelb; George Kokotos
Journal:  Bioorg Med Chem       Date:  2016-03-02       Impact factor: 3.641

Review 5.  Membrane and inhibitor interactions of intracellular phospholipases A2.

Authors:  Varnavas D Mouchlis; Edward A Dennis
Journal:  Adv Biol Regul       Date:  2015-12-19

Review 6.  Review of four major distinct types of human phospholipase A2.

Authors:  Alexis M Vasquez; Varnavas D Mouchlis; Edward A Dennis
Journal:  Adv Biol Regul       Date:  2017-10-23

7.  Insights on the molecular mechanism of anti-inflammatory effect of formula from Islamic traditional medicine: An in-silico study.

Authors:  Abdullah A Elgazar; Hamada Ramadan Knany; Mohammed Soliman Ali
Journal:  J Tradit Complement Med       Date:  2018-10-05

Review 8.  Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2.

Authors:  Aikaterini Nikolaou; Maroula G Kokotou; Sofia Vasilakaki; George Kokotos
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-23       Impact factor: 4.698

9.  Small Peptides Able to Suppress Prostaglandin E₂ Generation in Renal Mesangial Cells.

Authors:  Sofia Vasilakaki; Oleksandr Pastukhov; Thomas Mavromoustakos; Andrea Huwiler; George Kokotos
Journal:  Molecules       Date:  2018-01-13       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.